The first-of-its-kind research recognizes that large numbers of people worldwide have been affected by the two conditions and need non-invasive, integrative therapies that can be scaled.
WASHINGTON, D.C. and BATH, U.K. – An international team of physicians and scientists recently completed the first peer-reviewed research into the available options for treating long Covid and Covid-19 vaccine injury that will lay the groundwork for a better understanding and potential future treatments for the two conditions.
The study, published this week in the MDPI journal, Microorganisms, cited the vascular harm commonly seen as a result of Covid-19 illness or after receiving a Covid-19 vaccine and the need for therapies for both direct and indirect treatment to counter the effects of the spike protein from Covid-19. The study also discussed a variety of treatments for long Covid and Covid-19 vaccine injury that have shown varying degrees of success, including nutritional support, establishing a healthy microbiome, and using drugs that can inhibit spike protein and neutralize its harmful effects.
“We are proud to partner with the World Council for Health on this important paper that I hope is the beginning of more research into these poorly understood conditions,” said Paul Marik, M.D., a co-author of the study and the chief scientific officer of the Front Line COVID-19 Critical Care Alliance (FLCCC). “I’m thankful to my colleagues who treat patients suffering from long Covid or vaccine injury every day. In most cases, these patients have nowhere else to go. This research should educate others on the reality of these conditions and how they can be treated.”
The study’s methodology included reviewing published data of clinical trials on mechanisms of harm of the Covid-19 spike protein, treatment protocols for long Covid and Covid-19 vaccine injury, and the evidence of the limited number of available meta-analyses on therapeutic interventions.
“People who are suffering from long Covid or have been harmed by the Covid vaccines are often ignored or have been abandoned by the medical establishment,” said Tess Lawrie, MBBCh, Ph.D., a co-author of the study and co-founder of the World Council for Health. “This research shows that there is clear scientific evidence that both long Covid and the Covid vaccines are responsible for spike protein-induced conditions that will require a significant investment of resources before we fully understand these conditions and how to treat them most effectively.”
“I am proud of this great research facilitated by our WCH Health and Science Committee,” Lawrie added. “ In addition to Dr Marik, I want to express my sincere gratitude to the paper’s lead author, Matthew Halma and co-author, Christof Plothe.”
The study was crowd-funded by public donations through the World Council for Health and can be found in the latest edition of Microorganisms here: https://www.mdpi.com/2076-2607/11/5/1308
About the Front Line COVID-19 Critical Care Alliance
The FLCCC Alliance was organized in March 2020 by a group of highly published, world-renowned critical care physicians and scholars with the academic support of allied physicians from around the world. FLCCC’s goal is to research and develop lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness, including long COVID and post-vaccine syndrome.
For more information: www.FLCCC.net
About the World Council for Health
The World Council for Health is a non-profit initiative for the people that is informed and funded by the people. Our global coalition of health-focused initiatives and civil society groups seeks to broaden public health knowledge and sense-making through science and shared wisdom. We are dedicated to safeguarding human rights and free will while empowering people to take control of their health and well-being.
For more information: https://worldcouncilforhealth.org/donate/
We are a people-powered platform for world health representing 190+ coalition partners in more than 49 countries.
This work is licensed under a Creative Commons Attribution 4.0 International License and is available for republishing and use as a Free Cultural Work.